Welcome to our dedicated page for Curtiss Wright SEC filings (Ticker: CW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Curtiss-Wright Corporation (NYSE: CW) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Curtiss-Wright is a global integrated business that supplies highly engineered products, solutions and services mainly to aerospace and defense markets, and critical technologies in commercial nuclear power, process and industrial markets. Its filings offer detailed insight into how these activities translate into financial results, risks and capital allocation decisions.
Through periodic reports such as Form 10-K and Form 10-Q, Curtiss-Wright presents segment information for Aerospace & Industrial, Defense Electronics, and Naval & Power, along with discussions of total aerospace and defense markets and total commercial markets. These documents typically include data on sales, operating income, operating margin, new orders, backlog and free cash flow, as well as commentary on factors such as product mix, restructuring initiatives and operational excellence programs.
Current reports on Form 8-K provide updates on specific events, including quarterly and annual earnings releases, changes to financial guidance, adoption of Rule 10b5-1 trading plans for share repurchases, and expansions of repurchase authorizations. These filings describe how Curtiss-Wright structures its repurchase programs, the amounts authorized, and the expected timing of purchases under those plans.
Stock Titan enhances access to these filings with AI-powered summaries that highlight key points from lengthy documents, helping users quickly understand segment performance, capital allocation actions and notable risk disclosures. Real-time updates from EDGAR, along with visibility into relevant forms such as 10-K, 10-Q and 8-K, allow investors and researchers to review Curtiss-Wright’s regulatory history and ongoing reporting in a structured, easy-to-navigate format.
The Vanguard Group filed Amendment No. 12 to a Schedule 13G/A reporting 0% ownership—0 shares—of Curtiss‑Wright Corp. The filing states that, January 12, 2026, The Vanguard Group, Inc. completed an internal realignment and certain subsidiaries will report beneficial ownership separately in reliance on SEC Release No. 34-39538.
The amendment lists the filer’s address and confirms no sole or shared voting or dispositive power over Curtiss‑Wright common stock. The signature block is dated 03/26/2026.
Curtiss-Wright Corporation is soliciting proxies for its 2026 annual meeting on May 7, 2026 in Davidson, North Carolina. Stockholders will vote on electing nine directors, ratifying Deloitte & Touche LLP as independent auditor for 2026, and approving on an advisory basis executive compensation.
The Board highlights strong governance practices, with 8 of 9 director nominees independent and all key committees fully independent. It reports very strong 2025 performance, including 11.6% adjusted organic sales growth, 18.5% adjusted operating margin, working capital at 19.2% of sales, and three-year total shareholder return in the 93rd percentile versus peers.
The proxy emphasizes a pay-for-performance compensation philosophy, robust clawback and stock ownership policies, and a comprehensive ESG and corporate social responsibility program, including cybersecurity, ethics, responsible sourcing, and community initiatives. Stockholders of record at the close of business on March 13, 2026, when 36,907,171 common shares were outstanding, are entitled to vote.
Curtiss-Wright Corporation Senior VP & Corporate Controller Gary A. Ogilby reported an open-market sale of 252 shares of Common Stock on March 18, 2026 at an average price of $689.14 per share. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 11, 2025. Following this sale, Ogilby directly holds 2,571 shares of Curtiss-Wright common stock.
Curtiss-Wright Corporation Executive VP and CFO K. Christopher Farkas reported an open-market sale of 1,265 shares of common stock at an average price of $689.69 per share. The sale was executed under a pre-arranged Rule 10b5-1 trading plan maintained by his financial advisor. Following this transaction, Farkas directly holds 4,253 shares of Curtiss-Wright common stock. The shares were sold in multiple trades at prices ranging from $681.18 to $699.31 per share.
CW filed a Form 144 reporting a proposed sale of 1,265 shares of Common Stock through UBS Financial Services (NYSE) tied to an RSU vesting on 03/16/2026.
The filing names K. Christopher Farkas and lists prior dispositions in the past three months: 3,105 shares sold on 02/18/2026 for $2,156,439.58 and 2,665 shares sold on 02/04/2026 for $1,669,034.61.
Curtiss-Wright EVP & Chief Growth Officer John C. Watts exercised 512 restricted stock units into common shares and sold 220 shares. The RSUs were granted on March 16, 2023 under the 2014 Omnibus Incentive Plan and cliff vested after a three-year period.
The 220 common shares were sold on the open market at an average price of $678.11 per share, in multiple trades between $671.53 and $681.02. According to the disclosure, the sale was made to cover tax obligations related to the vesting, and Watts remains in compliance with the company’s share ownership guidelines.
Following these transactions, Watts directly holds 4,182 shares of Curtiss-Wright common stock and 895 restricted stock units, including dividend credits earned on prior grants.
Form 144 filing reports proposed dispositions of Common Stock linked to RSUs for CW. The filing lists an intended sale reported through UBS Financial Services and shows prior dispositions by Gary Ogilby: $272,427.46 for 02/04/2026 (435 shares), $272,400.00 for 02/03/2026 (435 shares), and $100,300.00 for 03/17/2026 (148 shares). The filing date appears as 03/18/2026.
Curtiss-Wright Senior VP & Treasurer Robert F. Freda reported equity award vesting and a small share sale. On March 16, 2026, 296 restricted stock units granted on March 16, 2023 under the 2014 Omnibus Incentive Plan cliff vested and converted into common stock at a $0.00 exercise price.
On March 17, 2026, he sold 140 shares of common stock in open-market transactions at an average price of $678.61 per share. Footnotes explain the sale was made to cover tax obligations in line with company share ownership guidelines, and that he remains in compliance. After the transactions, he directly holds 5,343 common shares, including dividend credits on prior grants.
Curtiss-Wright Senior VP & Corp Controller Gary A. Ogilby reported a combination of equity vesting and a small share sale. On March 16, 2026, 400 shares of common stock were acquired at $0.00 per share through the vesting and conversion of restricted stock units granted in 2023 under the company’s 2014 Omnibus Incentive Plan. On March 17, 2026, he sold 148 shares of common stock at an average price of $678.30 per share. Footnotes state the sale was made to cover tax obligations associated with the vesting and that he remains in compliance with the company’s share ownership guidelines. Following these transactions, he directly holds 2,823 shares of common stock and 4,420 restricted stock units, including dividend credits.